VinicioAlbertoDe Jesus PerezMD

PubMed

• 20 citations
  NOVEL MECHANISMS TARGETED BY DRUG TRIALS IN PULMONARY ARTERIAL HYPERTENSION
  David Condon, Stuti Agarwal, Ananya Chakraborty, Natasha Auer, Rocio Vazquez
  Chest. 2021-10-13
• 23 citations
  Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance.
  John A. Gebe, Koshika Yadava, Shannon M. Ruppert, Payton L. Marshall, Paul Hill
  American Journal of Respiratory Cell and Molecular Biology. 2017-01-01
• 13 citations
  Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative.
  Muhammad H Gul, Zin Mar Htun, Vinicio de Jesus Perez, Muhammad Suleman, Samiullah Arshad
  Respiratory Research. 2023-02-21

Journal Articles

• Molecular pathogenesis and current pathology of pulmonary hypertension  
  VA de Jesus Perez, Heart Fail Rev, 1/22/2015
• Assessment of pulmonary arterial wall anatomy in humans and pig (sus scrofa) using optical coherence tomography  
  NW Brunner, RT Zamanian, F Ikeno, Y Mitsutake, AJ Connolly, E Shuffle, K Yuan, M Orcholski, J Lyons and VA de Jesus Perez, Comparative Medicine, 1/1/2015
• Loss-of BMPR2 is associated with abnormal DNA repair in pulmonary arterial hypertension  
  M Li, S Vattulainen, J Aho, M Orcholski, V Rojas, K Yuan, VA de Jesus Perez, M Helenius, P Taimen, S Myllykangas, J Koskenvuo, TP Alastalo, Am J Resp Mol Cell Biol, 1/1/2014
• Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1  
  ZA Ali, VA de Jesus Perez, S Pan, A Raiesdana, NJ Leeper, X Qu, K Zaleta-Rivera, M Oguri, K Kato, Y Yamada, K Channon, M Rabinovitch, A Charest, T Quertermous, EA Ashley, J Clin Invest, 1/1/2014
• Development of a recurrent pleural effusion in a patient with pulmonary arterial hypertension treated with imatinib  
  OM Fortenko, L Melendres-Groves, A Richter, X Liao, E Spiekerkoetter, RT Zamanian, VA De Jesus Perez, Case Reports in Clinical Medicine, 1/1/2013
• Diagnosis and Management of pulmonary hypertension associated with left ventricular diastolic dysfunction  
  VA de Jesus Perez, F Haddad and RT Zamanian, Pulmonary Circulation, 1/1/2012
• Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension  
  F Haddad, T Peterson, E,Fuh, K Kudelko, VA de Jesus Perez, M Skhiri, R Vagelos , I Schnittger, AY Denault, DN Rosenthal, R Doyle and RT Zamanian, Circ Heart Fail, 1/1/2011
• PPAR gamma protects against pulmonary arterial hypertension and is central in a novel antiproliferative BMP-2-PPAR gamma-ApoE-axis in smooth muscle cells  
  Georg Hansmann, Vinicio A. de Jesus Perez, Janine Powers, Stefan Schellong, Lingli Wang, Takashi Urashima and Marlene Rabinovitch, Circulation, 1/1/2006
• Bone morphogenetic protein receptor 2 and Wingless 3a stimulate human pulmonary artery smooth muscle cell motility via activation of a Rho and Rac dependent non-canoni...  
  Vinicio A. de Jesus Perez, Georg Hansmann, Edda Spiekerkoetter and Marlene Rabinovitch, Circulation, 1/1/2006
• Join now to see all

Abstracts/Posters

• Whole exome sequencing leads to discovery of novel gene variants in PAH
  VA de Jesus Perez, AHA Scientific Sessions, 1/1/2012
• Recruitment of Disheveled by Integrin Linked Kinase 1 Regulates Bone Morphogenetic Protein 2 Induced Pulmonary Smooth Muscle Cell Motility
  VA de Jesus Perez, American Heart Association Scientific Sessions, 1/1/2009
• Bone Morphogenetic Protein 2 promotes pulmonary artery smooth muscle cell motility via cross-talk with both Wnt/b-catenin and Wnt/RhoA-Rac1 pathways
  Vinicio A. de Jesus Perez and Marlene Rabinovitch, American Thoracic Society Annual Meeting, 1/1/2007
• Bone Morphogenetic Protein 2 (BMP-2) and Wingless 3a (Wnt 3a) Promote Angiogenesis in the Pulmonary Circulation via Cross-talk through the Wnt/b-Catenin and Wnt/Rho Ra...
  Vinicio A. de Jesus Perez, Jeffrey Axelrod, Manuel Amieva and Marlene Rabinovitch, American Society of Cell Biology Annual Meeting, 1/1/2006
• BMP-2 and Wnt 3a control similar functions in pulmonary artery endothelial and smooth muscle cells
  Vinicio A. de Jesus Perez, Georg Hansmann and Marlene Rabinovitch, American Thoracic Society, 1/1/2006
• Join now to see all

Lectures

• Wall Center Video Series “What you need to know about the Pathology of PAH” 
  1/1/2015
• Whole exome sequencing for the discovery of novel genetic modifiers in PAH Genomic Predisposition and Therapeutic Avenues in Pulmonary Hypertension 
  1/1/2015
• BMPR2 and Wnt signaling BMPR2 and Pulmonary Hypertension at the Crossroads 
  1/1/2015
• Methamphetamine induced pulmonary hypertension Novel insights Into genetic basis and therapeutic opportunities 
  1/1/2015
• Obtaining Your First Faculty Position Early Career entitled Tricks and the Trade: Pearls and Pitfalls for Early Career 
  1/1/2015
• Don’t Panic: A Patient’s Guide to Understanding and Dealing with Pulmonary Hypertension 
  1/1/2015
• Wnt Signaling at the cross-roads of pulmonary angiogenesis 
  1/1/2013
• Current and Novel therapies in PAH 
  1/1/2013
• Current Diagnosis and Management of PAH 
  1/1/2013
• Challenges and pitfalls in the diagnosis of pulmonary hypertension associated with left heart disease 
  1/1/2013
• Genetics and Genomic of PAH 
  1/1/2013
• The role of BMP and Wnt signaling in pulmonary hypertension 
  1/1/2012
• A tale of two pathways-BMP and Wnt signaling in the pulmonary circulation 
  1/1/2011
• The role of BMP and Wnt signaling in pulmonary angiogenesis 
  1/1/2010
• Recruitment of Disheveled by Integrin Linked Kinase in Pulmonary Smooth Muscle Cell Motility 
  1/1/2009
• Bone Morphogenetic Protein 2 (BMP-2) and Wingless 3a (Wnt 3a) Promote Pulmonary Artery Endothelial Cell (PAEC) Migration via Cross-talk thru the Noncanonical Wnt/Plana... 
  1/1/2007
• BMP-2 and Wnt 3a Activate Wnt/Rho-Rac pathway in pulmonary artery smooth muscle cells via induction of fibronectin 
  1/1/2004
• Join now to see all